DCF — CLAXTON HEPBURN MEDICAL CENTER
Enterprise Value: $-259.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-259.0M
Enterprise Value
$-80.2M
PV of Cash Flows
$-178.8M
PV of Terminal Value
$-287.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $110.1M | $-17.1M | -16.0% | $-21.7M | $-19.8M |
| Year 2 | $113.4M | $-16.5M | -15.0% | $-21.3M | $-17.6M |
| Year 3 | $116.8M | $-15.8M | -14.0% | $-20.7M | $-15.6M |
| Year 4 | $120.4M | $-15.7M | -13.0% | $-20.8M | $-14.2M |
| Year 5 | $124.0M | $-15.8M | -13.0% | $-21.1M | $-13.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-259.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$106.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16012622043660663
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5